We are happy to announce that our manuscript describing engineering of the novel inherently fluorescent HER2-specific cytotoxic conjugate for selective elimination of breast cancer cells and for breast cancer imaging was published by one of the world-top journals in medicinal chemistry field. The first and co-corresponding author of this work is Natalia Porębska. Congratulations.
Link to publication: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00782
